[1]
M. Galli, P. Stefanoni, L. Paris, C. Pavoni, F. Delaini, and A. Rambaldi, “Elotuzumab in multiple myeloma: a single centre experience”, Eur J Oncol Env Hea, vol. 23, no. 2, pp. 72–79, Dec. 2018, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/7498